Active ingredient
Temazepam
88 finished FDA listings contain Temazepam as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- TEMAZEPAM
- Dosage forms
- Capsule
- Routes
- Oral
- Manufacturers / labelers
- 22
- Strengths listed
- 15 mg/1 · 22.5 mg/1 · 30 mg/1 · 7.5 mg/1
- Brand names in FDA listings
- Restoril, Temazepam
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 10355
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 018163 | SPECGX LLC | 1981-02-27 | 13 |
| ANDA 071456 | NOVEL LABS INC | 1987-04-21 | 17 |
| ANDA 071457 | NOVEL LABS INC | 1987-04-21 | 27 |
| ANDA 071620 | ACTAVIS ELIZABETH | 1987-08-07 | 5 |
| ANDA 201781 | PRINSTON INC | 2015-06-04 | 4 |
| ANDA 203482 | AMNEAL PHARMS | 2016-05-23 | 7 |
| ANDA 211542 | ALEMBIC | 2018-11-23 | 14 |
Official labeling on DailyMed
- TEMAZEPAM CAPSULE [BRYANT RANCH PREPACK] · version 104 · 2026-09-10
- TEMAZEPAM CAPSULE [BRYANT RANCH PREPACK] · version 106 · 2026-09-10
- TEMAZEPAM CAPSULE [MAJOR PHARMACEUTICALS] · version 10 · 2026-09-10
- TEMAZEPAM CAPSULE [BRYANT RANCH PREPACK] · version 22 · 2026-09-10
- TEMAZEPAM CAPSULE [PD-RX PHARMACEUTICALS, INC.] · version 24 · 2026-08-11
- TEMAZEPAM CAPSULE [ASCEND LABORATORIES, LLC] · version 23 · 2026-08-07
- TEMAZEPAM CAPSULE [REMEDYREPACK INC.] · version 14 · 2026-07-27
- RESTORIL (TEMAZEPAM) CAPSULE [SPECGX LLC] · version 25 · 2026-06-15
- TEMAZEPAM CAPSULE [SPECGX LLC] · version 16 · 2026-06-10
- TEMAZEPAM CAPSULE [AMNEAL PHARMACEUTICALS LLC] · version 23 · 2026-02-13
- TEMAZEPAM CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC ] · version 2 · 2026-02-10
- TEMAZEPAM CAPSULE [PREFERRED PHARMACEUTICALS INC.] · version 5 · 2026-01-16
Showing the 12 most recent of 55 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.